Top

Neurology and Therapy

Published in:

Open Access 24-10-2023 | Subarachnoid Hemorrhage | ORIGINAL RESEARCH

Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey

Authors: Shigeyuki Tahara, Fumio Otsuka, Takaaki Endo

Published in: Neurology and Therapy | Issue 1/2024

Abstract

Introduction

Individuals with traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH) are at a high risk of hypopituitarism, and should benefit from early diagnosis and management. However, data on awareness, attitudes, and practices of physicians treating hypopituitarism post-TBI/SAH are limited. The objectives of this study were to gain an understanding of the awareness of Japanese neurosurgeons and endocrinologists towards hypopituitarism post-TBI/SAH and the need for pituitary function assessments in these patients; and to assess the practices and perspectives of these specialists on screening patients with this condition.

Methods

An observational, cross-sectional study was performed that included a Web-based survey of practicing neurosurgeons managing ≥ 1 new patients with TBI/SAH per year or endocrinologists with ≥ 1 new patients per year with a history of TBI/SAH.

Results

Of the 316 respondents (201 neurosurgeons [male, 95.5%]; 115 endocrinologists [male, 77.4%]), 75.6% of neurosurgeons and 81.7% of endocrinologists were aware of the probable occurrence of hypopituitarism post-TBI/SAH, and 79% neurosurgeons and 93.8% endocrinologists considered pituitary function impairment after TBI/SAH to be either very important or important. Hypopituitarism after TBI/SAH was recognized as an important concern by both neurosurgeons (79%) and endocrinologists (93.8%). Although many respondents agreed that such patients remain undiagnosed and untreated, pituitary function assessment post-TBI/SAH has only been performed to a limited extent. The awareness that post-TBI/SAH hypopituitarism is often transient and can progress over several weeks or months was lower in neurosurgeons (46.8%) than in endocrinologists (66.1%).

Conclusions

The level of awareness of hypopituitarism post-TBI/SAH was lower among Japanese neurosurgeons than among endocrinologists. Educational programs and detailed guidance for the diagnosis and treatment of hypopituitarism post-TBI/SAH are warranted.

Available only for authorised users

GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:56–87. https://doi.org/10.1016/S1474-4422(18)30415-0.CrossRef

Toida C, Muguruma T, Gakumazawa M, et al. Age- and severity-related in-hospital mortality trends and risks of severe traumatic brain injury in Japan: a nationwide 10-year retrospective study. J Clin Med. 2021;10:1072. https://doi.org/10.3390/jcm10051072.CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention; National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention. Report to congress: the management of traumatic brain injury in children. 2018, Atlanta. https://www.cdc.gov/traumaticbraininjury/pdf/reportstocongress/managementoftbiinchildren/TBI-ReporttoCongress-508.pdf. Accessed 21 Nov 2022.

[No Authors Listed]. Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH consensus development panel on rehabilitation of persons with traumatic brain injury. JAMA. 1999;282:974–83.

Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology. 2020;54:171–9. https://doi.org/10.1159/000506396.CrossRefPubMed

Ikawa F, Morita A, Nakayama T, et al. A register-based SAH study in Japan: high incidence rate and recent decline trend based on lifestyle. J Neurosurg. 2020;134:983–91. https://doi.org/10.3171/2020.1.JNS192848.CrossRefPubMed

Kgosidialwa O, Hakami O, Muhammad Zia-Ul-Hussnain H, et al. Growth hormone deficiency following traumatic brain injury. Int J Mol Sci. 2019;20:3323. https://doi.org/10.3390/ijms20133323.CrossRefPubMedPubMedCentral

Tanriverdi F, Schneider HJ, Aimaretti G, et al. Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev. 2015;36:305–42. https://doi.org/10.1210/er.2014-1065.CrossRefPubMed

Popovic V, Aimaretti G, Casanueva FF, et al. Hypopituitarism following traumatic brain injury. Growth Horm IGF Res. 2005;15:177–84. https://doi.org/10.1016/j.ghir.2005.02.003.CrossRefPubMed

10.

Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, et al. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007;298:1429–38. https://doi.org/10.1001/jama.298.12.1429.CrossRefPubMed

11.

Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet. 2016;388:2403–15. https://doi.org/10.1016/S0140-6736(16)30053-8.CrossRefPubMed

12.

Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, et al. Hypopituitarism. Lancet. 2007;369:1461–70. https://doi.org/10.1016/S0140-6736(07)60673-4.CrossRefPubMed

13.

Karamouzis I, Pagano L, Prodam F, et al. Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS). Endocrine. 2016;52:441–50. https://doi.org/10.1007/s12020-015-0796-2.CrossRefPubMed

14.

Yuen KCJ, Masel B, Jaffee MS, et al. A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury. Growth Horm IGF Res. 2022;66:101495. https://doi.org/10.1016/j.ghir.2022.101495.CrossRefPubMed

15.

Emelifeonwu JA, Wiggins AN, Andrews PJD. A national survey of clinical practice of surveillance for post-traumatic brain injury hypopituitarism in the United Kingdom and Ireland. Br J Neurosurg. 2020;34:20–3. https://doi.org/10.1080/02688697.2019.1699902.CrossRefPubMed

16.

World Medical Association. WMA Declaration of Helsinki–ethical principles for medical research involving human subjects. 2022. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 26 Aug 2022.

17.

International Council for Harmonisation. Efficacy guidelines. 2022. https://www.ich.org/page/efficacy-guidelines. Accessed 26 Aug 2022.

18.

Nishioka H, Shimatsu A. Adult growth hormone deficiency: a practical approach to diagnosis and treatment for neurosurgeons. Jpn J Neurosurg. 2022;31:313–23. https://doi.org/10.7887/jcns.31.313.CrossRef

19.

Pharmaceuticals and Medical Devices Agency (PMDA). Sogroya subcutaneous injection interview form. 2022. https://www.info.pmda.go.jp/go/interview/1/620023_2412403G1020_1_004_1F.pdf. Accessed 21 Nov 2022.

20.

Tan CL, Alavi SA, Baldeweg SE, et al. The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance. J Neurol Neurosurg Psychiatry. 2017;88:971–81. https://doi.org/10.1136/jnnp-2016-315500.CrossRefPubMed

21.

Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am. 2020;104:213–38. https://doi.org/10.1016/j.mcna.2019.11.001.CrossRefPubMed

Title: Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey
Authors: Shigeyuki Tahara
Fumio Otsuka
Takaaki Endo
Publication date: 24-10-2023
Publisher: Springer Healthcare
Keywords: Subarachnoid Hemorrhage
Subarachnoid Hemorrhage
Hypopituitarism
Central Nervous System Trauma
Published in: Neurology and Therapy / Issue 1/2024
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI: https://doi.org/10.1007/s40120-023-00553-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE

An Integrative Nomogram for Identifying Cognitive Impairment Using Seizure Type and Cerebral Small Vessel Disease Neuroimaging Markers in Patients with Late-Onset Epilepsy of Unknown Origin

Improving shared decision making in multiple sclerosis

Design and Validation of a Clinical Outcome Measure for Adolescents and Adult Patients with Spinal Muscular Atrophy: SMA Life Study Protocol

Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management Challenges